Palvella Therapeutics Chief Scientific Officer Jeffrey S. Martini reports disposal of $2.08 million in common shares
PVLA•Chief Scientific Officer Jeffrey S. Martini sold 12,500 Palvella Therapeutics common shares on Nov. 10–11, 2026, reported as a $2.08 million disposal.
1. Share transactions
Martini exercised options for 4,266 shares at $7.53 each and 8,234 shares at $9.79 each before selling 12,500 common shares. After the transactions, he held no common shares directly, while options covering 36,141 shares remained.
